Login  |  Register

Pazopanib: A Formulary Dossier - slideshare.net

Pazopanib (VotrientTM) is a multi-target tyrosine kinase inhibitor approved by the FDA for the treatment of renal cell carcinoma. Renal cell carcinoma is the most ...

Alexa Traffic


Listing Links